
Globe LifeGL
Quality and valuation
How Globe Life compares with other financials stocks. A description, not a recommendation.
MET
AFL
PRU
PFG
GLGlobe Life and 4 life & health insurance peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.
An average business among financials companies, priced below most of them.
Globe Life trades at 9.8 times the next 12 months of expected earnings, against a median of 13.0x for the 84 financials stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.
- Revenue grew slower than the sector median: +5.2% vs +10.2%
- Turns less of its sales into cash: 19.9% vs 20.3%
- Keeps less of its revenue as profit (net margin): 19.6% vs 20.7%
Financials
From Globe Life's SEC filings, through the quarter ending 30 Jun 2026. Hover or tap a bar for its value.
| Last 12 months | GL | Sector median |
|---|---|---|
| Revenue growth | +5.2% | +10.2% |
| Free cash flow margin | 19.9% | 20.3% |
| Price to earnings | 10.6x | 14.6x |
Stories on Globe Life
We haven't written about Globe Life yet. Follow it, and its first story will show under My stocks on the front page.
Similar companies
Life & Health Insurance, by market value.
| Company | Price | Today |
|---|---|---|
METMetLife | $100.02 | −0.80% |
AFLAflac | $123.89 | +0.28% |
PRUPrudential Financial | $116.45 | −0.36% |
PFGPrincipal Financial Group | $111.63 | −1.78% |